The Drug Delivery Special Interest Group (SIG) met on Wednesday, December 7, 2022, to feature talks from the following:
- Brett H. Pogostin, Rice University - "Antigen Delivery via a Nanofibrous Peptide Hydrogel Elicits a Strong Bias Towards Humoral Immunity"
- Olivia Lanier, PhD; The University of Texas at Austin - "Developing an Oral Delivery Platform for siRNA Using Intelligent Nanotechnology Systems for Treatment of Inflammatory Bowel Diseases"
- Pere Dosta Pons, PhD; Brigham and Women’s Hospital, Harvard Medical School - "Conjugated STING-agonist Nanoparticles Enhance Antitumor Immunity in Multiple Tumor Models"
- Oluwatobi (Tobi) Babayemi; Rice University - "Characterizing Nanoparticle Fate in the CNS After Intrathecal Administration: A PET/CT Imaging Approach"
The recording can also be accessed directly here.